Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 2,547

Document Document Title
WO/2018/124572A1
The present invention relates to a silicon resin composition, a preparation method therefor, and a scar treatment agent including the same and, more specifically, to a silicon resin composition, a preparation method therefor, and a scar ...  
WO/2018/121706A1
Curable organopolysiloxane compositions and their cured products with superior properties is described as well as their uses as materials for optical devices, such as LEDs.  
WO/2018/115257A1
The invention relates to water-containing hydrogels for dressing wounds, comprising a polyurethane-polyurea copolymer having a polyvalent alcohol, except propylene glycol.  
WO/2018/115453A1
The invention relates to a water-containing hydrogel composition, comprising elemental silver particles, and a multi-layer wound dressing comprising the hydrogel composition. The multi-layer wound dressing is used in particular in the in...  
WO/2018/116287A1
Provided are compositions comprising an anion exchanger and a calcium salt for use as a medicament for inducing hemostasis at a site of bleeding; and methods of preparation thereof.  
WO/2018/109051A1
The invention relates to a composition for dressing cutaneous lesions, in particular cutaneous leishmanial lesions or cutaneous lesions due to actinic keratosis, comprising, based on the total weight of the composition: - 10.0 weight per...  
WO/2018/109275A1
The present application relates to a medical hydrogel comprising nanofibrillar cellulose, wherein the hydrogel has a viscosity in the range of 2500–9000 Pa·s and a water retention value in the range of 30–100 g/g. The present applic...  
WO/2018/108256A1
The invention relates to a composition for cutaneous lesion dressing of cutaneous leishmanial lesions, comprising, based on the total weight of the composition: - 10.0 weight percent to 35 weight percent of a one or more diols, selected ...  
WO/2018/109281A1
The present disclosure relates to method for drying hydrogel comprising nanofibrillar cellulose, the method comprising providing a hydrogel comprising nanofibrillar cellulose, providing polyethylene glycol, providing trehalose, mixing th...  
WO/2018/109282A1
The present disclosure relates to method for drying cell-free tissue extract in a hydrogel comprising nanofibrillar cellulose, the method comprising providing a hydrogel comprising nanofibrillar cellulose, providing cell-free tissue extr...  
WO/2018/104937A1
The present invention relates to antimicrobial formulations. More particularly, the invention relates to monovalent copper-containing and/or monovalent copper-generating products for healing wounds and burns, and particularly for chronic...  
WO/2018/101720A1
The present invention relates to a medical device for curing a liquid bandage and a method for curing a liquid bandage using same. According to an embodiment of the present invention, the medical device for curing a liquid bandage includ...  
WO/2018/097425A1
The present invention relates to a method for manufacturing a porous hydrogel sheet, and a porous hydrogel sheet manufactured by the manufacturing method, the method comprising the steps of: (1) preparing a hydrogel sheet composition sol...  
WO/2018/090913A1
A degradable and absorbable hemostatic fiber material, a preparation method therefor, and a hemostatic fiber article thereof. The carboxylation degree of the hemostatic fiber material is 10-25%, and the polymerization degree of the hemos...  
WO/2018/091890A1
Compositions for generating antimicrobial activity are described. The compositions comprise: a first phase; a second phase; an enzyme that is able to convert a substrate to release hydrogen peroxide;and a substance that includes a substr...  
WO/2018/087779A1
The present subject matter describes a transdermal spray device and a transdermal delivery system maintained by the device. The device comprises means (101, 102, 103) for storing and dispensing of a transdermal delivery system, and at le...  
WO/2018/080352A1
The present invention relates to the field of pharmaceutics and medicine, in particular, to a method for producing a suspended form of ground decellularized extracellular matrix with size-controlled structural components, the suspended f...  
WO/2018/078340A1
The invention provides liquid formulations comprising dissolved oxygen (e.g. 10 mg/L up to 100 mg/L dissolved oxygen), and a substance which is capable of forming a gel upon contact with a body surface or body tissues, wherein said gel i...  
WO/2018/080221A1
The present invention relates to a biopolymer-based hydrogel as a functional biomaterial using crosslinking with a photopolymerization initiator, and a method for producing the same. The present invention is biocompatible and elastic, an...  
WO/2018/075018A1
The inventive subject matter provides kits, compositions and methods for treating or covering skin using a polymerizable formulation. The polymerizable formulation can include a first component including a siloxane polymer and a catalyst...  
WO/2018/073837A1
The present invention relates to a topical dressing composition for the treatment of damaged skin tissue in a subject, wherein said topical dressing comprises mesenchymal stem cells embedded in a topical matrix. Particularly the inventio...  
WO/2018/071278A1
Film-forming gel compositions, useful in creating conformable and flexible gel bandages, can be formulate from a film-forming polymer, an amine-rich adhesion promoter, and a volatile solvent. The gel compositions form relatively thick fi...  
WO/2018/064390A1
Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents.  
WO/2018/064445A1
Compositions that are suitable for use as a disinfectant are disclosed. Methods of making and using compositions that are suitable for use as a disinfectant are also disclosed.  
WO/2018/050700A1
The invention relates to the ophthalmic field of biomedical devices. The present invention is directed to an aqueous photo-curable polysaccharide solution with cross- linking properties. Also, the invention is directed to an aqueous phot...  
WO/2018/052951A1
The inventive subject matter provides compositions and methods for transiently or permanently treating or managing an injury. Contemplated compositions are polymerizable in situ over short time periods, even in the presence of blood, wit...  
WO/2018/042378A1
The polysaccharide released from the unicellular cyanobacterium Cyanothece sp. CCY 0110 exhibits low cytotoxicity and proves to be suitable for the delivery of macromolecules. The cyanobacterium extracellular polymer disclosed in the pre...  
WO/2018/035475A1
Delivery articles for wound and surgical site treatment to prevent adhesion, provide antimicrobial benefits, and provide tissue scaffolding or support. The articles include (1) a dispensing unit or similar apparatus, the dispensing unit ...  
WO/2018/029340A1
The invention relates to a kit to prepare an hemostatic flowable comprising: -A hemostatic powder having a composition comprising: onon-cross-linked collagen of the fibrillar type comprising a content of fibrous collagen and/or fibrillar...  
WO/2018/030631A1
The present invention relates to a visible light-curable water-soluble chitosan derivative, a hydrogel, and a preparation method therefor and, more specifically, to a visible light-curable glycol chitosan derivative which is cured by lig...  
WO/2018/026204A1
The present invention relates to a method for preparing a sustained-release oxygen omission type in situ cross-linked hydrogel using calcium peroxide. The novel form of oxygen omission type in situ cross-linked hydrogel thus prepared is ...  
WO/2018/021637A1
The present invention relates to a composition, which is for repairing rotator cuff tears and includes nucleic acid and chitosan. More specifically, a composition for repairing rotator cuff tears and prepared by mixing nucleic acid and c...  
WO/2018/017549A1
Disclosed herein are wound healing products and methods of making and using the same. The wound healing product comprises a porous scaffold and collagen bound thereon. The scaffold may comprise a a poly(L-lactide-co-8-caprolactone) polym...  
WO/2018/007595A1
The present disclosure relates to a medical dressing comprising a carrier material and a composite material. The composite material comprises oil droplets dispersed in a matrix. The matrix comprises one or more cellulose derivatives and ...  
WO/2018/004739A1
The present invention provides thin-film forming compositions comprising an antiseptic (e.g., povidone iodine, chlorhexidine, or octenidine), a non-aqueous solvent, and a film-forming material dissolved in the non-aqueous solvent, wherei...  
WO/2017/214631A1
Methods for treating a wound with a wound packing are discussed. While the wound packing can include any suitable component, in some cases, it includes a collection of multi-potent cells (e.g., cells from bone marrow, amniotic membrane t...  
WO/2017/210421A1
Hemostatic powders are synergistically used in conjunction with self-assembling peptide hydrogels to promote hemostasis at a target site. Related methods, kits, and devices for hemostasis are disclosed.  
WO/2017/191416A1
The present invention relates to a composition which has a low affinity with respect to latex gloves, comprising a hydrophobic matrix, characterized in that said hydrophobic matrix comprises: - for 100 parts by weight of a mixture P of 2...  
WO/2017/186168A1
A medical hydrogel composition, a medical hydrogel, a preparation method therefore and an application thereof, and a medical hydrogel kit. The medical hydrogel composition comprises a first component and a second component; the first com...  
WO/2017/174874A1
One embodiment provides a method for preparing a medical product, said method comprising providing an aqueous dispersion of nanofibrillar cellulose, providing a layer of gauze, impregnating the layer of gauze with the aqueous dispersion ...  
WO/2017/177225A1
An immune-modulating biomaterial comprising a hydrogel scaffold coupled to D-amino acid containing peptides having unexpected properties in vivo is described. For example, certain inflammatory reactions in vivo are significantly increase...  
WO/2017/163603A1
The present invention provides a composition for replenishing the nucleus pulposus of an intervertebral disc, the composition containing a monovalent metal salt of a low endotoxin alginic acid. The composition is applied to a nucleus pul...  
WO/2017/158250A1
The invention relates to the field of silicone gels that are adhesive to the skin, able to be used in particular for articles that are adhesive to the skin for medical or paramedical use.  
WO/2017/158249A1
The invention relates to the field of silicone gels that are adhesive to the skin, able to be used in particular for articles that are adhesive to the skin for medical or paramedical use.  
WO/2017/139514A1
Compositions, methods and apparatuses for phototherapy to treat skin disorders. In particular, described herein are methods, compositions, phototherapy dressings for use with phototherapy UV light applicators (sources) and phototherapy U...  
WO/2017/127717A1
A biocompatible analyte sensing material for intradermal or subcutaneous application includes a collection of microgel particles having one or more network crosslinker components and an endogenous or exogenous annealing agent that links ...  
WO/2017/127452A1
A formulation is disclosed for use in wound healing. The formulation may include hvpochlorous acid, a silicone polymer or blend thereof, sodium phosphate, hydrochloric acid, and sodium magnesium silicate. Methods of using and making the ...  
WO/2017/125687A1
The present invention relates to a novel cryogenic composition intended to be used in heat treatment devices, and to the method of preparing same. The invention also relates to a heat treatment device and, more particularly, to a medical...  
WO/2017/117995A1
A chitosan-containing fibrin glue and use method thereof. The chitosan-containing fibrin glue comprises first lyophilized powder and second lyophilized powder, wherein components of the first lyophilized powder comprise fibrinogen, facto...  
WO/2017/117996A1
A biological product for surgical hemostasis and use method thereof. The biological product for surgical hemostasis comprises first lyophilized powder and second lyophilized powder, wherein components of the first lyophilized powder comp...  

Matches 1 - 50 out of 2,547